Acceleron Pharma, Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced that the company will host a conference call and live audio webcast to report its third quarter financial results and provide a corporate update on November 6, 2013, at 9:00 AM EST.
Help employers find you! Check out all the jobs and post your resume.
